These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34056242)

  • 1. Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation.
    Ivanova L; Rausalu K; Ošeka M; Kananovich DG; Žusinaite E; Tammiku-Taul J; Lopp M; Merits A; Karelson M
    ACS Omega; 2021 Apr; 6(16):10884-10896. PubMed ID: 34056242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
    Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
    Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors.
    Ivanova L; Rausalu K; Žusinaite E; Tammiku-Taul J; Merits A; Karelson M
    ACS Omega; 2021 Mar; 6(8):5786-5794. PubMed ID: 33681617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and Validation of Novel Chikungunya Virus Protease Inhibitors.
    Das PK; Puusepp L; Varghese FS; Utt A; Ahola T; Kananovich DG; Lopp M; Merits A; Karelson M
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7382-7395. PubMed ID: 27736770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach.
    Merten EM; Sears JD; Leisner TM; Hardy PB; Ghoshal A; Hossain MA; Asressu KH; Brown PJ; Stashko MA; Herring L; Mordant AL; Webb TS; Mills CA; Barker NK; Streblow ZJ; Perveen S; Arrowsmith C; Arnold JJ; Cameron CE; Streblow DN; Moorman NJ; Heise M; Willson TM; Popov K; Pearce KH
    bioRxiv; 2024 May; ():. PubMed ID: 38562906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease.
    Dhindwal S; Kesari P; Singh H; Kumar P; Tomar S
    J Biomol Struct Dyn; 2017 Dec; 35(16):3522-3539. PubMed ID: 27844505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site.
    Narwal M; Singh H; Pratap S; Malik A; Kuhn RJ; Kumar P; Tomar S
    Int J Biol Macromol; 2018 Sep; 116():451-462. PubMed ID: 29730006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches.
    Nguyen PT; Yu H; Keller PA
    J Mol Graph Model; 2015 Apr; 57():1-8. PubMed ID: 25622129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors.
    El-labbad EM; Ismail MA; Abou Ei Ella DA; Ahmed M; Wang F; Barakat KH; Abouzid KA
    Chem Biol Drug Des; 2015 Dec; 86(6):1518-27. PubMed ID: 26212366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue.
    Rausalu K; Utt A; Quirin T; Varghese FS; Žusinaite E; Das PK; Ahola T; Merits A
    Sci Rep; 2016 Nov; 6():37124. PubMed ID: 27845418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2.
    Utt A; Das PK; Varjak M; Lulla V; Lulla A; Merits A
    J Virol; 2015 Mar; 89(6):3145-62. PubMed ID: 25552719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease.
    Singh H; Mudgal R; Narwal M; Kaur R; Singh VA; Malik A; Chaudhary M; Tomar S
    Biochimie; 2018 Jun; 149():51-61. PubMed ID: 29635044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patent perspective on chikungunya.
    Dapurkar D; Telang M
    Acta Trop; 2019 Nov; 199():105131. PubMed ID: 31401192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-Conjugating Enzyme E2 L3 is Downregulated by the Chikungunya Virus nsP2 Protease.
    Ramphan S; Khongwichit S; Saisawang C; Kovanich D; Ketterman AJ; Ubol S; Auewarakul P; Roytrakul S; Smith DR; Kuadkitkan A
    Proteomics Clin Appl; 2018 Jul; 12(4):e1700020. PubMed ID: 28975709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.
    Göertz GP; McNally KL; Robertson SJ; Best SM; Pijlman GP; Fros JJ
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease.
    Singh KhD; Kirubakaran P; Nagarajan S; Sakkiah S; Muthusamy K; Velmurgan D; Jeyakanthan J
    J Mol Model; 2012 Jan; 18(1):39-51. PubMed ID: 21445710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages.
    Nayak TK; Mamidi P; Sahoo SS; Kumar PS; Mahish C; Chatterjee S; Subudhi BB; Chattopadhyay S; Chattopadhyay S
    Front Immunol; 2019; 10():786. PubMed ID: 31031770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors.
    Kumar P; Kumar D; Giri R
    Pathogens; 2019 Aug; 8(3):. PubMed ID: 31443266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.